ES8502103A1 - Procedimiento para la obtencion de amidas del acido piperazin-1-il-acetico substituido - Google Patents

Procedimiento para la obtencion de amidas del acido piperazin-1-il-acetico substituido

Info

Publication number
ES8502103A1
ES8502103A1 ES532011A ES532011A ES8502103A1 ES 8502103 A1 ES8502103 A1 ES 8502103A1 ES 532011 A ES532011 A ES 532011A ES 532011 A ES532011 A ES 532011A ES 8502103 A1 ES8502103 A1 ES 8502103A1
Authority
ES
Spain
Prior art keywords
acetic
preparation
acid amides
substituted piperazin
piperazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532011A
Other languages
English (en)
Other versions
ES532011A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Cassella Farbwerke Mainkur AG
Original Assignee
Cassella AG
Cassella Farbwerke Mainkur AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella AG, Cassella Farbwerke Mainkur AG filed Critical Cassella AG
Publication of ES532011A0 publication Critical patent/ES532011A0/es
Publication of ES8502103A1 publication Critical patent/ES8502103A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE AMIDAS DEL ACIDO PIPERAZIN-1-IL-ACETICO SUSTITUIDO.CONSISTE EN: A) HACER REACCIONAR UNA AMINA DE ACIDO PIPERAZIN-1-IL-ACETICO DE FORMULA (II) CON UN AGENTE DE ACILACION DE FORMULA (III), QUE INTRODUCE EL RADICAL ACILO R-CO; B) HACER REACCIONAR UNA PIPERAZINA DE FORMULA (IV) CON UN COMPUESTO DE FORMULA (V); Y C) HACER REACCIONAR UN DERIVADO DE ACIDO PIPERAZIN-1-IL-ACETICO DE FORMULA (VI) CON UNA AMINA DE FORMULA (VIII), PARA OBTENER NUEVAS AMIDAS DE ACIDO PIPERAZIN-1-IL-ACETICO DE FORMULA (I), DONDE R ES FENILO, MONO, DI- O TRISUSTITUIDO CON ALQUILO C 1 A 4 Y OTROS; R ES AMINO, ALQUILAMINO CON C 1 A 4 Y OTROS; R ES HIDROXI, ALCOXI C 1 A 4 Y OTROS; R ES FENILO, METOXIFENILO Y OTROS; N ES 2 O 3; M ES 1 O 2; E Y ES HAL Y OTROS.TIENE APLICACION FARMACOLOGICA POR SU ACCION ENCEFALOTROPICA.
ES532011A 1983-04-28 1984-04-27 Procedimiento para la obtencion de amidas del acido piperazin-1-il-acetico substituido Expired ES8502103A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833315424 DE3315424A1 (de) 1983-04-28 1983-04-28 Substituierte piperazin-1-yl-essigsaeure-amide, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
ES532011A0 ES532011A0 (es) 1984-12-16
ES8502103A1 true ES8502103A1 (es) 1984-12-16

Family

ID=6197594

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532011A Expired ES8502103A1 (es) 1983-04-28 1984-04-27 Procedimiento para la obtencion de amidas del acido piperazin-1-il-acetico substituido

Country Status (19)

Country Link
US (1) US4610984A (es)
EP (1) EP0123977A1 (es)
JP (1) JPS59205363A (es)
KR (1) KR840008347A (es)
AU (1) AU2747384A (es)
CA (1) CA1202304A (es)
CS (2) CS244849B2 (es)
DD (1) DD223711A5 (es)
DE (1) DE3315424A1 (es)
DK (1) DK147784A (es)
ES (1) ES8502103A1 (es)
FI (1) FI841461A (es)
GR (1) GR81494B (es)
HU (1) HUT34178A (es)
IL (1) IL71657A0 (es)
NO (1) NO841464L (es)
PL (2) PL253669A1 (es)
PT (1) PT78488B (es)
ZA (1) ZA843138B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512163D0 (en) * 1985-05-14 1985-06-19 Fujisawa Pharmaceutical Co Oxothiazolidine compound
US5110929A (en) * 1986-08-07 1992-05-05 Medice Cham.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of N-alkylated quaternary nitrogen containing aromatic heterocycles
IT1249728B (it) * 1991-11-06 1995-03-09 Sigma Tau Ind Farmaceuti Derivati delle prolinammide quali attivatori della memoria e dei processi di apprendimento e composizioni farmaceutiche che li contengono
DE19904710A1 (de) * 1999-02-05 2000-08-10 Aventis Pharma Gmbh Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
EP1909797A4 (en) * 2005-08-02 2013-02-27 Neurogen Corp DIPIPERAZINYL KETONE AND RELATED ANALOG

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081564A1 (en) * 1970-03-05 1971-12-10 Delalande Sa N-amino carbonyl-piperazines analgesics - antiinflammatories ,hypotensives and spasmolytics
BE774447A (fr) * 1970-11-11 1972-02-14 Biasedra Lab Nouveaux derives de la salicylamide et leur application en therapeutique
US4247549A (en) * 1978-12-27 1981-01-27 Ici Americas Inc. Piperazine-1-carboxylic acid esters possessing antidepressant or analgesic activity
US4585774A (en) * 1981-05-08 1986-04-29 Otsuka Pharmaceutical Co., Ltd. Aniline derivatives and cardiotonic composition

Also Published As

Publication number Publication date
EP0123977A1 (de) 1984-11-07
AU2747384A (en) 1984-11-01
CS244811B2 (en) 1986-08-14
CS307184A2 (en) 1985-09-17
GR81494B (es) 1984-12-11
PT78488B (de) 1986-05-22
CS121785A2 (en) 1985-09-17
FI841461A (fi) 1984-10-29
PT78488A (de) 1984-05-01
CS244849B2 (en) 1986-08-14
DK147784A (da) 1984-10-29
PL247414A1 (en) 1985-10-08
FI841461A0 (fi) 1984-04-12
DD223711A5 (de) 1985-06-19
ZA843138B (en) 1984-11-28
NO841464L (no) 1984-10-29
ES532011A0 (es) 1984-12-16
US4610984A (en) 1986-09-09
DE3315424A1 (de) 1984-12-20
IL71657A0 (en) 1984-07-31
DK147784D0 (da) 1984-02-29
CA1202304A (en) 1986-03-25
JPS59205363A (ja) 1984-11-20
HUT34178A (en) 1985-02-28
PL253669A1 (en) 1986-02-11
KR840008347A (ko) 1984-12-14

Similar Documents

Publication Publication Date Title
DE3467751D1 (en) Process for the treatment of glycerine by distillation
ES8305761A1 (es) Un procediemiento para la preparacion de lactamas biciclicas.
ES8600737A1 (es) Procedimiento de preparar compuestos de sulfonio
ES8603425A1 (es) Un procedimiento para preparar 1-amino-4-nitro-acridinonas sustituidas
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
DE3061061D1 (en) Process for the purification of caprolactam
IT1224144B (it) Procedimento per il trattamento dei tessili
ES8502103A1 (es) Procedimiento para la obtencion de amidas del acido piperazin-1-il-acetico substituido
DE3462025D1 (en) Process for the production of 2,3,5-trimethylbenzoquinone
DE3460169D1 (en) Process for the manufacture of 3-hydroxytetrahydrofuran
PL247724A1 (en) Process for preparing 1,8-dihydoxy-10-acyl-9-anthrones,especially for treatment of psoriasis
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
FI844900L (fi) Foerfarande foer framstaellning av 4,5,6,7-tetrahydrotiazolo/5,4-c/pyridinderivat.
AU570070B2 (en) Dibromobenzylcyclohexylamine compounds for the treatment of infections
GB8311206D0 (en) Treatment of eczema
ES8601849A1 (es) Un procedimiento para la preparacion de ariloxicicloalcanolaminoalquilen aril cetonas
EP0104961A3 (en) Process for the treatment of clay for eliminating impurities based on titanium
DE3463036D1 (en) Process for the cyclization of orthobenzoylbenzoic acid
DE3063912D1 (en) Process for the purification of n,n-dialkylaminoethanols by hydrogenation
CA1034056A (en) Process for the purification of cyanogen chloride
CA1264325C (en) AROYLIMIDAZOLONES
DE3166798D1 (en) Process for the purification of 2-pyrrolidone
IT7922250A0 (it) Metodo per la purificazione di caprolattame grezzo.
IT7922355A0 (it) Metodo per la purificazione del caprolattame grezzo contenente ammidi ed altri sottoprodotti.
DE3475411D1 (en) Process for the treatment of starch or raw materials containing starch